Shandong University Cancer Center, Shandong University, Jinan, Shandong, China.
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
J Transl Med. 2023 May 12;21(1):320. doi: 10.1186/s12967-023-04154-y.
Anti-PD-(L)1 immunotherapy has been recommended for non-small cell lung cancer (NSCLC) patients with lymph node metastases (LNM). However, the exact functional feature and spatial architecture of tumor-infiltrating CD8 + T cells remain unclear in these patients.
Tissue microarrays (TMAs) from 279 IA-IIIB NSCLC samples were stained by multiplex immunofluorescence (mIF) for 11 markers (CD8, CD103, PD-1, Tim3, GZMB, CD4, Foxp3, CD31, αSMA, Hif-1α, pan-CK). We evaluated the density of CD8 + T-cell functional subsets, the mean nearest neighbor distance (mNND) between CD8 + T cells and neighboring cells, and the cancer-cell proximity score (CCPS) in invasive margin (IM) as well as tumor center (TC) to investigate their relationships with LNM and prognosis.
The densities of CD8 + T-cell functional subsets, including predysfunctional CD8 + T cells (T) and dysfunctional CD8 + T cells (T), in IM predominated over those in TC (P < 0.001). Multivariate analysis identified that the densities of CD8 + T cells in TC and CD8 + T cells in IM were significantly associated with LNM [OR = 0.51, 95%CI (0.29-0.88), P = 0.015; OR = 5.80, 95%CI (3.19-10.54), P < 0.001; respectively] and recurrence-free survival (RFS) [HR = 0.55, 95%CI (0.34-0.89), P = 0.014; HR = 2.49, 95%CI (1.60-4.13), P = 0.012; respectively], independent of clinicopathological factors. Additionally, shorter mNND between CD8 + T cells and their neighboring immunoregulatory cells indicated a stronger interplay network in the microenvironment of NSCLC patients with LNM and was associated with worse prognosis. Furthermore, analysis of CCPS suggested that cancer microvessels (CMVs) and cancer-associated fibroblasts (CAFs) selectively hindered CD8 + T cells from contacting with cancer cells, and were associated with the dysfunction of CD8 + T cells.
Tumor-infiltrating CD8 + T cells were in a more dysfunctional status and in a more immunosuppressive microenvironment in patients with LNM compared with those without LNM.
抗 PD-(L)1 免疫疗法已被推荐用于有淋巴结转移 (LNM) 的非小细胞肺癌 (NSCLC) 患者。然而,这些患者肿瘤浸润 CD8+T 细胞的确切功能特征和空间结构仍不清楚。
使用多重免疫荧光 (mIF) 对 279 例 IA-IIIB NSCLC 样本的组织微阵列 (TMA) 进行 11 种标志物 (CD8、CD103、PD-1、Tim3、GZMB、CD4、Foxp3、CD31、αSMA、Hif-1α、pan-CK) 的染色。我们评估了浸润边缘 (IM) 和肿瘤中心 (TC) 中 CD8+T 细胞功能亚群的密度、CD8+T 细胞与邻近细胞之间的平均最近邻距离 (mNND) 和癌症细胞邻近评分 (CCPS),以研究它们与 LNM 和预后的关系。
IM 中 CD8+T 细胞功能亚群(包括前功能失调 CD8+T 细胞 (T) 和功能失调 CD8+T 细胞 (T))的密度高于 TC (P<0.001)。多变量分析确定 TC 中 CD8+T 细胞和 IM 中 CD8+T 细胞的密度与 LNM [比值比 (OR)=0.51,95%可信区间 (CI) (0.29-0.88),P=0.015;OR=5.80,95%CI (3.19-10.54),P<0.001] 和无复发生存 (RFS) [风险比 (HR)=0.55,95%CI (0.34-0.89),P=0.014;HR=2.49,95%CI (1.60-4.13),P=0.012] 显著相关,独立于临床病理因素。此外,CD8+T 细胞与其邻近免疫调节细胞之间较短的 mNND 表明 LNM 患者的微环境中存在更强的相互作用网络,并且与预后不良相关。此外,CCPS 分析表明,癌微血管 (CMVs) 和癌相关成纤维细胞 (CAFs) 选择性地阻止 CD8+T 细胞与癌细胞接触,并与 CD8+T 细胞的功能障碍相关。
与无 LNM 患者相比,有 LNM 的患者肿瘤浸润的 CD8+T 细胞处于更功能失调的状态和更具免疫抑制性的微环境中。